The FDA's reclassification of Hydrocodone to a Schedule II controlled substance takes effect on October 6, 2014. This will put medications such as Vicodin, Lortab and their generics in the same class as medications containing codeine and oxycodone. While this has been debated for more than a decade, the FDA took action last year. The final rule was posted to the Federal Register on 22 August 2014, and may be viewed at http://go.usa.gov/mc8d The summary reads: "With the issuance of this final rule, the Administrator of the Drug Enforcement Administration reschedules hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule II controlled substances...